Last reviewed · How we verify
NCT05991089: TUN-CKDH
Tunisian Clinical Registry on Chronic Kidney Disease in Hypertensive Patients
trial in Chronic Kidney Diseases in 11,770 participants. Completed in 1 July 2024.
1 July 2024
Quick facts
| Lead sponsor | Dacima Consulting |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 11,770 |
| Start date | 8 January 2024 |
| Primary completion | 1 July 2024 |
| Estimated completion | 1 July 2024 |
| Sites | 1 location across Tunisia |
Conditions studied
- Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
- Hypertension — all drugs for Hypertension →
Sponsor
Dacima Consulting
Who can join
18 and older, any sex, with Chronic Kidney Diseases or Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In Tunisia, high blood pressure (HTN) is a public health problem whose prevalence varies from 28.7% to 34.7%. Hypertension can be both, cause and consequence of chronic kidney disease, and its prevalence is quite high in this population. It is both a risk factor for mortality and cardiovascular morbidity, but also a major cause of terminal chronic kidney disease becoming an additional public health concern. Detecting and diagnosing chronic kidney in all hypertensives at an early stage remains a global public health challenge. A well-conducted treatment makes it possible to reach the blood pressure objective but also to reduce the risk of occurrence of a cardiovascular event and to slow the progression of chronic kidney disease. In Tunisia, few data exists concerning the prevalence of chronic kidney disease in hypertensive subjects, thus limiting the development and elaboration of preventive measures. A national survey will thus be conducted by the "Kidney and Metabolic Diseases" Working Group under the aegis of the Tunisian Society of Nephrology, Dialysis and Kidney Transplantation. The main objective is to estimate the prevalence of chronic kidney disease in hypertensive tunisian patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05991089
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Kidney Diseases
Currently open trials in the same condition.
- NCT06593392 — Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus · Phase 2 · recruiting
- NCT07358572 — Eye-Brain-Kidney in CKD · recruiting
- NCT06463483 — Automated Insulin Delivery in Adults With Advanced Kidney Disease · NA · recruiting
- NCT06927024 — Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD) · NA · recruiting
- NCT07115953 — Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension · NA · recruiting
Other Dacima Consulting trials
Trials by the same sponsor.
- NCT07034274 — National Tunisian Clinical Registry on CardioVascular Secondary Prevention Clinical · recruiting
- NCT06934499 — Tunisian Lung Cancer Study · recruiting
- NCT06825533 — The Prevalence of Prediabetes in Primary Care Medicine in Tunisia · not yet recruiting
- NCT06445036 — Tunisian Clinical Registry on Hypoparathyroidism and Pseudo-hypoparathyroidism · not yet recruiting
- NCT05577650 — Prevalence of Chronic Kidney Disease in Tunisian Diabetics · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05991089 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dacima Consulting
- Last refreshed: 5 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05991089.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing